Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Cancer Discovery (2023) Vol. 14, Iss. 3, pp. 424-445
Open Access | Times Cited: 23

Showing 23 citing articles:

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Varadha Balaji Venkadakrishnan, Adam G. Presser, Richa Singh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
In Memory of Dr. Felix Feng
Himisha Beltran
European Urology (2025)
Closed Access
Prostate cancer epigenetics — from pathophysiology to clinical application
Vera Constâncio, João Lobo, José Pedro Sequeira, et al.
Nature Reviews Urology (2025)
Closed Access
Emergence of Neuroendocrine Tumors in Patients Treated with Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer: A Systematic Review and Meta-analysis
Denis Séguier, Pauline Parent, Martine Duterque‐Coquillaud, et al.
European Urology Oncology (2025)
Closed Access
DNA methylation in human diseases
Samareh Younesian, Mohammad Hossein Mohammadi, Ommolbanin Younesian, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32366-e32366
Open Access | Times Cited: 2
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma
Talal El Zarif, Karl Semaan, Marc Eid, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114350-114350
Open Access | Times Cited: 2
NETest in advanced high‐grade gastroenteropancreatic neuroendocrine neoplasms
Halfdan Sørbye, Geir Olav Hjortland, L. W. Vestermark, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 11
Open Access | Times Cited: 2
The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms
Catarina Serra-Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3349-3349
Open Access | Times Cited: 2
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Varadha Balaji Venkadakrishnan, Adam G. Presser, Richa Singh, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Varadha Balaji Venkadakrishnan, Adam G. Presser, Richa Singh, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
Pradeep S. Chauhan, Irfan Alahi, Savar Sinha, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 1, pp. 151-163
Closed Access | Times Cited: 1
Recent advances in basic research on prostate cancer: Where we are heading?
Daisuke Obinata, Yasutaka Yamada, Takayuki Sumiyoshi, et al.
International Journal of Urology (2024)
Open Access | Times Cited: 1
The 30th Annual Prostate Cancer Foundation Scientific Retreat Report
Andrea K. Miyahira, Howard R. Soule
The Prostate (2024) Vol. 84, Iss. 14, pp. 1271-1289
Closed Access
Bioinformatics analysis reveals that CBX2 promotes enzalutamide resistance in prostate cancer
Wen Zhu, Qinghua Li, Guangmo Hu
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey‐Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira, Marina N. Sharifi, Lisa N. Chesner, et al.
The Prostate (2024) Vol. 85, Iss. 3, pp. 211-226
Closed Access
Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer
Zoe R. Maylin, Christopher D. Smith, Adam Classen, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1999-1999
Open Access
Understanding the molecular regulators of neuroendocrine prostate cancer
Sreyashi Bhattacharya, Avery Stillahn, Kaitlin Smith, et al.
Advances in cancer research (2024), pp. 403-429
Closed Access
Sensitive tumor detection, accurate quantification, and cancer subtype classification using low-pass whole methylome sequencing of plasma DNA
Marta Paoli, Francesca Galardi, Agostina Nardone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma
Nicole M. Naranjo, Anne Marie Kennedy, Anna Testa, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Casting a wider net: The clinical potential of EV transcriptomics in multi-analyte liquid biopsy
Yari Ciani, Caterina Nardella, Francesca Demichelis
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1160-1162
Closed Access
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
Xiaolin Zhu, Tatyanah Farsh, Daniël J. Vis, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 19
Open Access
Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, et al.
European Urology Oncology (2024)
Closed Access
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers
Pedro C. Barata, Kevin Zarrabi, Axel Bex, et al.
European Urology (2024)
Closed Access
Page 1

Scroll to top